Please login to the form below

constipation

This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.

Shire bags US approval for constipation drug Motegrity

Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like

Latest news

Immunology keeps Shire figures solid as Takeda takeover nears

HAE, prucalopride (SHP555) for chronic idiopathic constipation, and calaspargase pegol (SHP663) for the treatment of acute lymphoblastic leukaemia (ALL).
Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
NICE backs Allergan's IBS therapy Truberzi

includes Linzess (linaclotide) for IBS with constipation.
Shire claims FDA approval for slow-cooked ADHD drug

Mydayis will reach the US market in the third quarter of the year
FDA fast-tracks Pfizer and Lilly's tanezumab

unpleasant side effects such as severe constipation.

More from news
Approximately 8 fully matching, plus 65 partially matching documents found.

Latest Intelligence

Erectile dysfunction, constipation, vaginal dryness and other laughing matters

Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile territory.
Taking a lean and careful approach

His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
Deal Watch March 2016

$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
Oral biologics delivery still elusive

years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
Medius Deal Watch table for March 2015

941. AstraZeneca / Daiichi Sankyo. Co-commercialisation US . Marketed Movantik (naloxegol) for opioid induced constipation.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

Ironwood appoints Edward Owens to board

irritable bowel syndrome and constipation.
Norgine’s Karen Hockey promoted to head of global marketing

Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation treatment Movicol since joining Norgine in 2011.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Account Director development role to Business Director, H...: Excellent package

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Medical Writer: Salary TBC

Account Manager / Account Director: Competative

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Account Manager: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director: Competitive Salary Offered

Business Director: Competitive Salary Offered

Medical Writer: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Senior Director – Healthcare PR – Global Agency: Salary TBC

Global Business Development Director – Health Education: excellent commission

Associate Director: £75, 000-90, 000

Account Director, Medical Education: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...